NCT05717894View on ClinicalTrials.gov

Possibilities of Phytomedicine in Monotherapy of Benign Breast Diseases

PHASE4CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

January 11, 2020

Primary Completion Date

May 15, 2022

Study Completion Date

June 10, 2022

Conditions
Fibrocystic Breast Disease
Interventions
DRUG

Vitex Agnus Castus Extract

The patient group received two pills containing 200mg of VAC daily for six months

Trial Locations (1)

Unknown

Kazakh Institute of Oncology and Radiology, Almaty

All Listed Sponsors
lead

Nazgul Omarbayeva

OTHER

NCT05717894 - Possibilities of Phytomedicine in Monotherapy of Benign Breast Diseases | Biotech Hunter | Biotech Hunter